Role of antigens and virulence factors of Salmonella enterica serovar Typhi in its pathogenesis

Microbiological Research

Volumn 167, Issue 4, 2012, Pages 199-210

  Kaur, Jasmine ^a   Jain, S K ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Pathogenesis; S. Typhi; SPI's; Type III secretion system; Virulence factors

Indexed keywords

PATHOGENESIS; S. TYPHI; SPI'S; TYPE III SECRETION SYSTEM; VIRULENCE FACTORS;

GENES;

SALMONELLA;

BACTERIAL ANTIGEN; VIRULENCE FACTOR;

ANTIGEN; BACTERIUM; BIOLOGICAL CONTROL; DEFENSE MECHANISM; DISEASE CONTROL; ETIOLOGY; MOLECULAR ANALYSIS; PATHOGENICITY; SECRETION; VIRULENCE;

BACTERIAL GENE; BACTERIAL SECRETION SYSTEM; GENOMIC ISLAND; HUMAN; METABOLISM; PATHOGENICITY; REVIEW; SALMONELLA TYPHI;

ANTIGENS, BACTERIAL; BACTERIAL SECRETION SYSTEMS; GENES, BACTERIAL; GENOMIC ISLANDS; HUMANS; SALMONELLA TYPHI; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI;

EID: 84858281716     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2011.08.001     Document Type: Review

References (150)

1. Abrahams G.L., Hensel M. Manipulating cellular transport and immune responses: dynamic interactions between intracellular Salmonella enterica and its host cells. Cell Microbiol 2006, 8:728-737.
2. Ahmer B.M., Tran M., Heffron F. The virulence plasmid of Salmonella typhimurium is self-transmissible. J Bacteriol 1999, 181:1364-1368.
3. Akinyemi K., Smith S., Oyefolu A., Coker A. Multidrug resistance in Salmonella enteric serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria. Public Health 2005, 119(4):321-327.
4. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 1999, 285:736-739.
5. Aliprantis A.O., Yang R.B., Weiss D.S., Godwski P., Zychlinsky A. The apoptotic signaling pathway activated by Toll-like receptor 2. EMBO J 2000, 19:3325-3336.
6. Alonso A., Garcia-del Portillo F. Hijacking of eukaryotic functions by intracellular bacterial pathogens. Int Microbiol 2004, 7:181-191.
7. Andrade D.R., Andrade D.R. Typhoid fever as cellular microbiological model. Rev Inst Med Trop Sao Paulo 2003, 45:185-191.
8. Ansong C., Yoon H., Norbeck A.D., Gustin J.K., McDermott J.E. Proteomics analysis of the causative agent of typhoid fever. J Proteome Res 2008, 7:546-557.
9. Bakowski M.A., Braun V., Lam G.Y., Yeung T., Heo W.D., Meyer T., et al. The phospho inositide phosphatase SopB manipulates membrane surface charge and trafficking of the Salmonella-containing vacuole. Cell Host Microbe 2010, 7:453-462.
10. Balows A., Hausler W.J., Hermann K.L., Isenberg H.D., Shadomy H.J. Manual of clinical microbiology 1991, American Society for Microbiology, Washington. 5th ed.
11. Bhunia R., Hutin Y., Ramakrishnan R., Pal N., Sen T., Murhekar M. A typhoid fever outbreak in a slum of South Dumdum Municipality, West Bengal, India, 2007: evidence for foodborne and waterborne transmission. BMC Public Health 2009, 9:115.
12. Braun V., Wong A., Landekic M., Hong W.J., Grinstein S., Brumell J.H. Sorting nexin3 (SNX3) is a component of a tubular endosomal network induced by Salmonella and involved in maturation of the Salmonella-containing vacuole. Cell Microbiol 2010, 12:1352-1367.
13. Broz P., Newton K., Lamkanfi M., Mariathasan S., Dixit V.M., Monack D.M. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med 2010, 207:1745-1755.
14. Bulut Y., Faure E., Thomas L., Equils O., Arditi M. Cooperation of Toll-like receptors 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001, 167:987-994.
15. Carlson S.A., Omary M.B., Jones B.D. Identification of cytokeratins as accessory mediators of Salmonella entry into eukaryotic cells. Life Sci 2002, 70:1415-1426.
16. Charles R.C., Harris J.B., Chase M.R., Lebrun L.M., Sheikh A., LaRocque R.C., et al. Comparative proteomic analysis of the PhoP regulon in Salmonella enterica Serovar Typhi versus Typhimurium. PLoS One 2009, 4(9):e6994. 10.1371/journal.pone.0006994.
17. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999, 274:10689.
18. Ciacci-Woolwine F., Blomfield I.C., Richardson S.H., Mizel S.B. Salmonella flagellin induces tumor necrosis factor α in a human promonocytic cell line. Infect Immun 1998, 66:1127-1134.
19. Cirillo D.M., Valdivia R.H., Monack D.M., Falkow S. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol Microbiol 1998, 30:175-188.
20. Corrotte M., Nyguyen A.P., Harlay M.L., Vitale N., Bader M.F., Grant N.J. Ral isoforms are implicated in Fc gamma R-mediated phagocytosis: activation of phospholipase D by RalA. J Immunol 2010, 185:2942-2950.
21. Cossart P., Boquet P., Normark S., Rappuoli R. Cellular microbiology emerging. Science 1996, 271:315-316.
22. Crum Cianflone N.F. Salmonellosis and the GI tract: more than just peanut butter. Curr Gastroenterol Rep 2008, 10(4):424-431.
23. Crump J.A., Mintz E.D. Global trends in typhoid and paratyphoid fever. Clin Infect Dis 2010, 50:241-246.
24. de Oliveira FA, Pasqualotto AP, da Silva WP, Tondo EC. Characterization of Salmonella enteritidis isolated from human samples. Food Res Int, in press, doi:10.1016/j.foodres.2010.09.040.
25. Denise M.M., Anne M., Stanley F. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2004, 2:747-765.
26. Dougan G., John V., Palmer S., Mastroeni P. Immunity to salmonellosis. Immunol Rev 2011, 240:196-210.
27. Faucher S.P., Porwollik S., Dozois C.M., McClelland M., Daigle F. Transcriptome of Salmonella enterica serovar Typhi within macrophages revealed through the selective capture of transcribed sequences. Proc Natl Acad Sci U S A 2006, 103:1906-1911.
28. Faucher S.P., Viau C., Gros P.P., Daigle F., Le Moual H. The prpZ gene cluster encoding eukaryotic-type Ser/Thr protein kinases and phosphatases is repressed by oxidative stress and involved in Salmonella enterica serovar Typhi survival in human macrophages. FEMS Microbiol Lett 2008, 281:160-166.
29. Feng Ying C. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg 2000, 62(5):644.
30. Feuillet V., Medjane S., Mondor I., Demaria O., Pagni P.P., Galan J.E., et al. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc Natl Acad Sci U S A 2006, 103:12487-12492.
31. Foley S.L., Lynne A.M. Food animal-associated Salmonella challenges: pathogenicity and antimicrobial resistance. J Anim Sci 2008, 86:E173-E187.
32. Franchi L., Amer A., Body-Malapel M., Kanneganti T.D., Ozoren N., Jagirdar R., et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in Salmonella-infected macrophages. Nat Immunol 2006, 7:576-582.
33. Gala'n J.E., Wolf-Watz H. Protein delivery into eukaryotic cells by type III secretion machines. Nature 2006, 444:567-573.
34. García-del Portillo F., Zwick M.B., Leung K.Y., Finlay B.B. Salmonella induces the formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells. Proc Natl Acad Sci U S A 1993, 90:10544-10548.
35. Garmendia J., Beuzon C.R., Ruiz-Albert J., Holden D.W. The roles of SsrA-SsrB and Ompr-Envz in the regulation of genes encoding the Salmonella typhimurium SPI-2 type III secretion system. Microbiology 2003, 149:2385-2396.
36. Garmony H.S., Brown K.B., Titball R.W. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev 2002, 26:339-353.
37. Gewirtz A.T., Reed K.A., Merlin D., Hobert M., Neish A.S., James L. Modeling microbial-epithelial interactions in the intestine. Methods Microbiol 2002, 31:377-396.
38. Goosney D.L., Knoechel D.G., Finlay B.B. Enteropathogenic E. coli, Salmonella, and Shigella: masters of host cell cytoskeletal exploitation. Emerg Infect Dis 1999, 5:216-223.
39. Griffin A.J., McSorley S.J. Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. Mucosal Immunol 2011 Jul, 4(4):371-382. 10.1038/mi.2011.2.
40. Groisman E.A., Ochman H. How Salmonella became a pathogen. Trends Microbiol 1997, 5:343-349.
41. Groisman E.A. The pleiotropic two-component regulatory system PhoP-PhoQ. J Bacteriol 2001, 183:1835-1842.
42. Guiney D.G., Fang F.C., Krause M., Libby S., Buchmeier N.A., Fierer J. Biology and clinical significance of virulence plasmids in Salmonella serovars. Clin Infect Dis 1995, 21(2):S146-S151.
43. Hamid N., Jain S.K. Characterization of an outer membrane protein of Salmonella enterica serovar typhimurium that confers protection against typhoid. Clin Vaccine Immunol 2008, (9):1461-1471.
44. Hamid N., Jain S.K. Immunogenic evaluation of a recombinant 49-kilodalton outer membrane protein of Salmonella typhi as a candidate for a subunit vaccine against typhoid. J Infect Dis Immun 2010, 2(2):30-40.
45. Hansen-Wester I., Hensel M. Salmonella pathogenicity islands encoding type III secretion systems. Microbes Infect 2001, 3:549-559.
46. Harris J.B., Bernal A.B., Rollins S.M., Alam A., LaRocque R.C., Bikowski M., et al. Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi. Infect Immun 2006, 74(9):5161-5168.
47. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103.
48. Helena M.B., Seth-Smith SPI-7: Salmonella's Vi-encoding pathogenicity island. J Infect Dev Countries 2008, 2(4):267-271.
49. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
50. Hensel M. Salmonella pathogenicity island 2. Mol Microbiol 2000, 36:1015-1023.
51. Hess J., Ladel C., Miko D., Kaufmann S.H. Salmonella typhimurium aroA-infection in gene targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN gamma in bacterial clearance independent of intracellular location. J Immunol 1996, 156:3321-3326.
52. Hoffmann J.A., Kafatos F.C., Janeway C.A., Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science 1999, 284:1313-1318.
53. Hohmann E.L., Oletta C.A., Killeen K.P., Miller S.I. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single dose typhoid fever vaccine in volunteers. J Infect Dis 1996, 173:1408-1414.
54. Holden D.W. Trafficking of the Salmonella vacuole in macrophages. Traffic 2002, 3:161-169.
55. Hormaeche C.E., Mastroeni P., Arena A., Uddin J., Joysey H.S. T-cells do not mediate the initial suppression of a Salmonella infection in the RES. Immunology 1990, 70:247-250.
56. Hornick R.B., Greisman S.E., Woodward T.E., DuPont H.L., Dawkins A.T., Snyder M. Typhoid fever: pathogenesis and immunologic control. N Engl J Med 1970, 283:686-691.
57. House D., Bishop A., Parry C.M., Dougan G., Wain J. Typhoid fever: pathogenesis and disease. Curr Opin infect Dis 2001, 14:573-578.
58. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 1998, 62:379-433.
59. Jain S.K. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever. Curr Opin Mol Ther 2009, 11:565-571.
60. Janeway C.A. Approaching the asymptote evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 1989, 54(1):1-13.
61. Johanns T.M., Ertelt J.M., Rowe J.H., Way S.S. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 2010, 6:e1001043.
62. Jonathan J., Deepak C., Michael H. Cellular aspects of immunity to intracellular Salmonella enterica. Immunol Rev 2011, 240:185-195.
63. Jones B.D., Paterson H.F., Hall A., Falkow S. Salmonella typhimurium induces membrane ruffling by a growth factor receptor-independent mechanism. Proc Natl Acad Sci U S A 1993, 90:10390-10394.
64. Khan A.Q., Zhao L., Hirose K., Miyake M., Li T., Hashimoto Y., et al. Salmonella typhi rpoS mutant is less cytotoxic than the parent strain but survives inside resting THP-1 macrophages. FEMS Microbiol Lett 1998, 161:201-208.
65. Knodler L.A., Steele-Mortimer O. Taking possession: biogenesis of the Salmonella-containing vacuole. Traffic 2003, 4:587-599.
66. Kuhle V., Hensel M. Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity Island 2. Cell Mol Life Sci 2004, 61:2812-2826.
67. Lapaque N., Hutchinson J.L., Jones D.C., Meresse S., Holden D.W., Trowsdale J., et al. Salmonella regulates polyubiquitination and surface expression of MHC class II antigens. Proc Natl Acad Sci U S A 2009, 106:14052-14057.
68. Lee A.H., Zareei M.P., Daefler S. Identification of a NIPSNAP homologue as host cell target for Salmonella virulence protein SpiC. Cell Microbiol 2002, 4:739-750.
69. Lee A.K., Detweiler C.S., Falkow S. OmpR regulates the two-component system Ssra-Ssrb in Salmonella Pathogenicity Island 2. J Bacteriol 2000, 182:771-781.
70. Levine M.M., Galen J.E., Tacket C.O., Barry E.M., Pasetti M.F., Sztein M.B. Attenuated strains of Salmonella enterica serovar Typhi as live oral vaccines against typhoid fever. New generation vaccines 2004, 479-486. Marcel Dekker, New York. 3rd ed. M.M. Levine, J.B. Kaper, R. Rappuoli, M. Liu, M. Good (Eds.).
71. Levine M.M., Tacket C.O., Sztein M.B. Host-Salmonella interaction: human trials. Microbes Infect 2001, 3:1271-1279.
72. Libby S.J., Brehm M.A., Greiner D.L., Shultz L.D., McClelland M., Smith K.D., et al. Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci U S A 2010, 107:15589-15594.
73. Lostroh C.P., Lee C.A. The Salmonella pathogenicity island-1 type III secretion system. Microbes Infect 2001, 3:1281-1291.
74. Lu S., Manges A.R., Xu Y., Fang F.C., Riley L.W. Analysis of virulence of clinical isolates of Salmonella enteritidis in vivo and in vitro. Infect Immun 1999, 67:5651-5657.
75. Mahieu T., Libert C. Should we inhibit type I interferons in sepsis. Infect Immun 2007, 75:22-29.
76. Majowicz S.E., Musto J., Scallan E., Angulo F.J., Kirk M., O'brien S.J., et al. The global burden of non typhoidal Salmonella gastroenteritis. Clin Infect Dis 2010, 50:882-889.
77. Malik-Kale P., Jolly C.E., Lathrop S., Winfree S., Luterbach C., Steele-Mortimer O. Salmonella - at home in the host cell. Front Microbiol 2011, 2(June (125)). 10.3389/fmicb.2011.00125.
78. Marlovits T.C., Stebbins C.E. Type III secretion systems shape up as they ship out. Curr Opin Microbiol 2010, 13:47-52.
79. Marlovits T.C., Kubori T., Sukhan A., Thomas D.R., Gala'n J.E., Unger V.M. Structural insights into the assembly of the type III secretion needle complex. Science 2004, 306:1040-1042.
80. -/- (B-cell deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 2000, 68:46-53.
81. Mastroeni P., Villarreal-Ramos B., Hormaeche C.E. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/C mice requires both immune serum and T cells. Infect Immun 1993, 61:3981-3984.
82. McGhie E.J., Hayward R.D., Koronakis V. Cooperation between actin-binding proteins of invasive Salmonella: SipA potentiates SipC nucleation and bundling of actin. EMBO J 2001, 20:2131-2139.
83. McGhie E.J., Brawn L.C., Hume P.J., Humphreys D., Koronakis V. Salmonella takes control: effector-driven manipulation of the host. Curr Opin Microbiol 2009, 12:117-124.
84. McSorley S.J., Jenkins M.K. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium. Infect Immun 2000, 68:3344-3348.
85. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
86. Miao E.A., Alpuche-Aranda C.M., Dors M., Clark A.E., Bader M.W., Miller S.I., et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nat Immunol 2006, 7:569-575.
87. Modlin R.L., Brightbill H.D., Godowski P.J. The Toll of innate immunity on microbial pathogens. N Engl J Med 1999, 340:1834-1835.
88. Morgan E. Salmonella pathogenicity islands. Salmonella: molecular biology and pathogenesis 2007, 67-88. Horizon Scientific Press, United Kingdom. M. Rhen, D. Maskell, P. Mastroeni, J. Threlfall (Eds.).
89. Morrison D.C., Ryan J.L. Endotoxins and disease mechanisms. Ann Rev Med 1987, 38:417-432.
90. Murli S., Watson R.O., Galán J.E. Role of tyrosine kinases and the tyrosine phosphatase SptP in the interaction of Salmonella with host cells. Cell Microbiol 2001, 3:795-810.
91. Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H. Manual of clinical microbiology 1995, ASM Press, Washington, DC, p. 450-2. 6th ed.
92. Mweu E., English M. Typhoid fever in children in Africa. Trop Med Int Health 2008, 13(4):532-540.
93. Myeni S.K., Zhou D. The C terminus of SipC binds and bundles F-actin to promote Salmonella invasion. J Biol Chem 2010, 285:13357-13363.
94. Nichols C.D., Casanova J.E. Salmonella-directed recruitment of new membrane to invasion foci via the host exocyst complex. Curr Biol 2010, 20:1316-1320.
95. Niemann G.S., Brown R.N., Gustin J.K., Stufkens A., Shaikh-Kidwai A.S., Li J., et al. Discovery of novel secreted virulence factors from Salmonella enterica serovar Typhimurium by proteomic analysis of culture supernatants. Infect Immun 2011, 33-43.
96. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J Immunol 2000, 164:3476-3479.
97. Ohl M.E., Miller S.I. Salmonella: a model for bacterial pathogenesis. Annu Rev Med 2001, 52:259-274.
98. Pallen M.J., Chaudhuri R.R., Henderson I.R. Genomic analysis of secretion systems. Curr Opin Microbiol 2003, 6:519-527.
99. Parkhill J., Dougan G., James K.D., Thomson N.R., Pickard D., Wain J., et al. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 2001, 413:848-852.
100. Patel J.C., Hueffer K., Lam T.T., Galan J.E. Diversification of a Salmonella virulence protein function by ubiquitin-dependent differential localization. Cell 2009, 137:283-294.
101. Pegues D.A., Ohl M.E., Miller S.I. Salmonella species, including Salmonella typhi. Principles and practice of infectious diseases 2005, 2636-2654. Churchill Livingstone, Philadelphia. G.L. Mandell, G.E. Bennet, R. Dolin (Eds.).
102. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
103. Prost L.R., Miller S.I. The Salmonellae PhoQ sensor: mechanisms of detection of phagosome signals. Cell Microbiol 2008, 10:576-582.
104. Pui C.F., Wong W.C., Chai L.C., Tunung R., Jeyaletchumi P., Noor Hidayah M.S., et al. Salmonella: a foodborne pathogen. Int Food Res J 2011, 18:465-473.
105. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P., et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999, 189:615-625.
106. Raffatellu M., Wilson R.P., Winter S.E., Bäumler A.J. Clinical pathogenesis of typhoid fever. J Infect Dev Countries 2008, 2(4):260-266.
107. Raucher D., Stauffer T., Chen W., Shen K., Guo S., York J.D., et al. Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell 2000, 100:221-228.
108. Rotger R., Casadesus J. The virulence plasmids of Salmonella. Int Microbiol 1999, 2:177-184.
109. Santos R.L., Tsolis R.M., Bäumler A.J., Adams L.G. Pathogenesis of Salmonella induced enteritis. Braz J Med Biol Res 2003, 36:3-12.
110. Santos Andrade J.R., Andrade TNF-α production and apoptosis in hepatocytes after listeria monocytogenes and Salmonella Typhimurium invasion. Rev Inst Med Trop Sao Paulo 2011, 53(2):107-112.
111. Schmidt H., Hensel M. Pathogenicity islands in bacterial pathogenesis. Clin Microbiol Rev 2004, 17:14-56.
112. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999, 274:17406-17409.
113. Shahane V., Muley V., Kagal A., Bharadwaj R. Non-typhoid Salmonellosis: emerging infection in Pune. Indian J Med Microbiol 2007, 25:173-174.
114. Sheikh A., Charles R.C., Rollins S.M., Harris J.B., Bhuiyan M.S., et al. Analysis of Salmonella enterica serotype Paratyphi A gene expression in the blood of bacteremic patients in Bangladesh. PLoS Negl Trop Dis 2010, 4(12):e908. 10.1371/journal.pntd.0000908.
115. Sheppard M., Webb C., Heath F., Mallows V., Emilianus R., Maskell D., et al. Dynamics of bacterial growth and distribution within the liver during Salmonella infection. Cell Microbiol 2003, 5:593-600.
116. Shi L., Ansong C., Smallwood H., Rommereim L., McDermott J.E., et al. Proteome of Salmonella Enterica serotype Typhimurium grown in a low Mg2+/pH medium. J Proteomics Bioinform 2009, 2:388-397. 10.4172/jpb.1000099.
117. Sinha K., Mastroeni P., Harrison J., de Hormaeche R.D., Hormaeche C.E. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect Immunol 1997, 65:1566-1569.
118. Srinivasan A., Nanton M., Griffin A., McSorley S.J. Culling of activated CD4 T cells during typhoid is driven by Salmonella virulence genes. J Immunol 2009, 182:7838-7845.
119. Steiner T.S. How flagellin and toll-like receptor 5 contribute to enteric infection. Infect Immun 2007, 75:545-552.
120. Sundquist M., Rydstrom A., Wick M.J. Immunity to Salmonella from a dendritic point of view. Cell Microbiol 2004, 6:1-11.
121. Sztein M. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica serovar typhi strains used as live oral vaccines in humans. Clin Infect Dis 2007, 45:S15-S19.
122. Tacket C.O., Sztein M.B., Wasserman S.S., Losonsky G., Kotloff K.L., Wyant T.L., et al. Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD908-htrA in US volunteers. Infect Immun 2000, 68:1196-1201.
123. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram positive bacterial cell wall components. Immunity 1999, 11:443-451.
124. Takeuchi O., Kawai T., Mühlradt P.F., Morr M., Radolf J.D., Zychlinsky A., et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001, 13:933-940.
125. Thomas M., Holden D.W. Ubiquitination - a bacterial 1 effector's ticket to ride. Cell Host Microbe 2009, 5:309-311.
126. Thompson L.J., Dunstan S.J., Dolecek C., Perkins T., House D., Dougan G., et al. Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc Natl Acad Sci U S A 2009, 106:22433-22438.
127. Thomson N., Baker S., Pickard D., Fookes M., Anjum M., Hamlin N., et al. The role of prophage-like elements in the diversity of Salmonella enteric serovars. J Mol Biol 2004, 339:279-300.
128. Tierrez A., Garcia-del Portillo F. New concepts in Salmonella virulence: the importance of reducing the intracellular growth rate in the host. Cell Microbiol 2005, 7:901-909.
129. Tobias P.S., Soldau K., Ulevitch R.J. Isolation of a lipopolysaccharide binding acute phase reactant from rabbit serum. J Exp Med 1986, 164:777-793.
130. Totemeyer S., Kaiser P., Maskell D.J., Bryant C.E. Sublethal infection of C57BL/6 mice with Salmonella enterica Serovar Typhimurium leads to an increase in levels of Toll-like receptor 1 (TLR1), TLR2, and TLR9 mRNA as well as a decrease in levels of TLR6 mRNA in infected organs. Infect Immun 2005, 73:1873-1878.
131. Uchiya K., Barbieri M.A., Funato K., Shah A.H., Stahl P.D., Groisman E.A. A Salmonella virulence protein that inhibits cellular trafficking. EMBO J 1999, 18:3924-3933.
132. Ulevitch R.J., Tobias P.S. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999, 11:19-22.
133. Unsworth K.E., Holden D.W. Identification and analysis of bacterial virulence genes in vivo. Philos Trans R Soc Lond B Biol Sci 2000, 355:613-622.
134. Vernikos G.S., Parkhill J. Interpolated variable order motifs for identification of horizontally acquired DNA: revisiting the Salmonella pathogenicity islands. Bioinformatics 2006, 22:2196-2203.
135. Vijay-Kumar M., Wu H., Jones R., Grant G., Babbin B., King T.P., et al. Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am J Pathol 2006, 169:1686-1700.
136. Villa L., Carattoli A. Integrons and transposons on the Salmonella enterica serovar Typhimurium virulence plasmid. Antimicrob Agents Chemother 2005, 49:1194-1197.
137. Wahid R., Salerno-Goncalves R., Tacket C.O., Levine M.M., Sztein M.B. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. Vaccine 2007, 25:1416-1425.
138. Wallis T.S., Galyov E.E. Molecular basis of Salmonella induced enteritis. Mol Microbiol 2000, 36:997-1005.
139. Waterman S.R., Holden D.W. Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cell Microbiol 2003, 5:501-511.
140. Weiss D.S., Raupach B., Takeda K., Akira S., Zychlinsky A. Toll-like receptors are temporally involved in host defense. J Immunol 2004, 172:4463-4469.
141. Wyant T.L., Tanner M.K., Sztein M.B. Salmonella typhi flagella are potent inducers of proinflammatory cytokine. Infect Immun 1999, 67:3619-3624.
142. Yang B., Qu D., Zhang X., Shen J., Cui S., Shi Y., et al. Prevalence and characterization of Salmonella serovars in retail meats of marketplace in Shaanxi, China. Int J Food Microbiol 2010, 141(1-2):63-72.
143. Yang R.B., Mark M.R., Gray A., Huang A., Xie M.H., Zhnag M., et al. Toll-like receptor-2 mediated lipoplysaccharide-induced cellular signaling. Nature 1998, 395:284-288.
144. Yang R.B., Mark M.R., Gurney A.L., Godowski P.J. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J Immunol 1999, 163:639-643.
145. Yoon H., Ansong C., McDermott J.E., Gritsenko M., Smith R.D., Heffron F., et al. Systems analysis of multiple regulator perturbations allows discovery of virulence factors in Salmonella. BMC Syst Biol 2011, 5:100.
146. Yoon H., McDermott J.E., Porwollik S., McClelland M., Heffron F. Coordinated regulation of virulence during systemic infection of Salmonella enterica serovar Typhimurium. PLoS Pathog 2009, 5:e1000306.
147. Yrlid U., Svensson M., Johansson C., Wick M.J. Salmonella infection of bone marrow derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response. FEMS Immunol Med Microbiol 2000, 27:313-320.
148. Yu H., Wang J., Ye J., Tang P., Chu C., Hu S., et al. Complete nucleotide sequence of pscv50, the virulence plasmid of Salmonella enterica serovar Choleraesuis SC-B67. Plasmid 2006, 55:145-151.
149. Zhang S., Kingsley R.A., Santos R.L., Andrews-Polymenis H., Raffatellu M., Figueiredo J., et al. Molecular pathogenesis of Salmonella enterica serotype Typhimurium-induced diarrhea. Infect Immun 2003, 71:1-12.
150. Zhang X.L., Jeza V.T., Pan Q. Salmonella Typhi: from a human pathogen to a vaccine vector. Cell Mol Immunol 2008, 5(2):9.